a.fetal, rel. al feto; ___ alcohol syndrome→síndrome alcohólico ___; ___ aspiration syndrome→síndrome de aspiración ___; ___ circulation→circulación ___; ___ death→muerte ___; ___ drug syndrome→síndrome ___ del abuso de droga; ...
Sayres LC, Allyse M, Norton ME, Cho MK (2011) Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 31(11):1070–1076Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of ...
NoneJohn Wiley & Sons, Ltd.American Journal of Medical Genetics Part ACell-free fetal DNA tests for trisomy show promise in women at lower risk of affected pregnancies. American Journal of Medical Genetics Part A 164 :10.1002/ajmg.a.v164a.6, viii-ix /...
A new type of prenatal screening however, offers parents-to-be a better option. Cell-Free Fetal DNA testing detects chromosomal abnormalities through a simple blood test that is more accurate than current screening tests and can be done earlier in pregnancy—as early as the 10th week, with res...
Objective. Fetal growth restriction (FGR) is associated with an increased risk of perinatal mortality and morbidity but can have many different causes. Non-cellular fetal DNA in maternal blood offers many opportunities for noninvasive prenatal diagnosis. It is likely that the source of the DNA is...
free fetal dna in maternal circulation—reply ravinder dhallan, md, phd ; michael cronin, phd ; sarah emche, phd ; et al philip bayliss, md ; marian damewood, md author affiliations jama. 2004;292(23):2835-2836. doi:10.1001/jama.292.23.2835-b full text in reply : dr lo and ...
ObjectiveTo determine the sensitivity and specificity of circulating cell-free fetal DNA in determining the fetal RHD status and fetal sex. MethodsMaternal blood was collected in each trimester of pregnancy from RhD negative nonalloimmunized women. Whole blood was centrifuged, separated into plasma an...
aCell-free fetal DNA in maternal plasma presents interest as it can possibly serve as a pregnancy associated biomarker. For its quantitation, we investigate the use of fluorescent polymerase chain reaction (PCR) amplification of short tandem repeats (STRs) in pregnancies irrespective of sex. 当它...
Current non-invasive prenatal screening (NIPS) analyzes circulating fetal cell-free DNA (cfDNA) in maternal peripheral blood for selected aneuploidies or microdeletion/duplication syndromes. Many genetic disorders are refractory to NIPS largely because t
Since the 1960s, there have been numerous attempts to use fetal nucleated cells that have entered into maternal blood for prenatal testing. However, the rarity of such cells has impeded this approach from becoming a clinical reality. Because cell-free tumor DNA has been detected in the plasma...